Media Library
icon
-
ImagelockManufacturing / Image
Novartis radioligand therapy (RLT) manufacturing facility
Exterior view of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. -
ImagelockManufacturing / Image
Radioligand therapy (RLT) production line
Highly trained specialists on the production line of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. -
ImagelockManufacturing / Image
Refrigeration room at a Novartis radioligand therapy (RLT) manufacturing facility
Examining materials inside the refrigeration room of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. -
ImagelockManufacturing / Image
Specialized equipment for the manufacture of radioligand therapy (RLT)
Using specialized equipment on the production line at our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. -
ImagelockManufacturing / Image
Quality control for environmental monitoring in radioligand therapy (RLT) manufacturing
Conducting quality control at our state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. -
ImagelockLeadership / Image
Patrick Horber, M.D.
President, International, since December 1, 2023 -
ImagelockLeadership / Image
Patrick Horber, M.D.
President, International, since December 1, 2023 -
ImagelockLeadership / Image
Patrick Horber, M.D.
President, International, since December 1, 2023 -
ImagelockLeadership / Image
Patrick Horber, M.D.
President, International, since December 1, 2023 -
ImagelockLeadership / Image
Michelle Weese
Chief Corporate Affairs Officer -
ImagelockLeadership / Image
Karen L. Hale
Chief Legal Officer -
ImagelockLeadership / Image
Karen L. Hale
Chief Legal Officer
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 14
- › Next page